Document is current
Any future updates will be listed below
-
Authors
Balaji Srinivasan, Sriraag
Sehly, Amro
Jaltotage, Biyanka
Qin, Simon
Ihdayhid, Abdul Rahman
Marangou, James
Rankin, James M.
Sanfilippo, Frank M.
Dwivedi, Girish https://orcid.org/0000-0003-0717-740X
-
Funding
Funding for this research was provided by:
University of Western Australia
- License Information
-
More Information
Article History
Received: 17 September 2022
Accepted: 20 September 2022
First Online: 29 September 2022
Declarations
:
: Ethics approval was obtained from the University of Western Australia Human Research Ethics Committee (UWA HREC RA/4/1/8065) and Western Australia Department of Health Human Research Ethics Committee (RGS2803), and the study was conducted according to the principles of the Declaration of Helsinki.
: BJ consults for the Artrya Pty Ltd. ARI consults and has equity interest in the Artrya Pty Ltd. GD received speaker bureau fees for Pfizer, Johnson and Johnson, and Amgen and conference sponsorship from Bayer and consults and has equity interest in the Artrya Pty Ltd. The other authors declare no competing interests.
